

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.19289372 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.79083406 |
| 3 | positive thymic T cell selection (GO:0045059) | 6.29693483 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.22453002 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.22453002 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.05651858 |
| 7 | negative T cell selection (GO:0043383) | 5.96629744 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.96307864 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.94958168 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.71103049 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.71103049 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 5.59521677 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 5.49212310 |
| 14 | response to interleukin-15 (GO:0070672) | 5.42767059 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.36981727 |
| 16 | positive T cell selection (GO:0043368) | 5.36016075 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 5.06563905 |
| 18 | * thymic T cell selection (GO:0045061) | 4.78116636 |
| 19 | leukocyte aggregation (GO:0070486) | 4.66871485 |
| 20 | interferon-gamma production (GO:0032609) | 4.65337581 |
| 21 | * T cell selection (GO:0045058) | 4.56888322 |
| 22 | T cell migration (GO:0072678) | 4.48046623 |
| 23 | tolerance induction (GO:0002507) | 4.41268543 |
| 24 | * regulation of B cell differentiation (GO:0045577) | 4.21123756 |
| 25 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.17366206 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 4.15314232 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.15022055 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 4.14170199 |
| 29 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.13211410 |
| 30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.07929920 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94840323 |
| 32 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.84629108 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.84349840 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.81305161 |
| 35 | * T cell costimulation (GO:0031295) | 3.79688849 |
| 36 | * T cell receptor signaling pathway (GO:0050852) | 3.78808544 |
| 37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.77847646 |
| 38 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76812812 |
| 39 | detection of bacterium (GO:0016045) | 3.74781945 |
| 40 | cellular response to zinc ion (GO:0071294) | 3.72029335 |
| 41 | * lymphocyte costimulation (GO:0031294) | 3.71950146 |
| 42 | positive regulation of granulocyte differentiation (GO:0030854) | 3.66118513 |
| 43 | detection of other organism (GO:0098543) | 3.62428991 |
| 44 | mature B cell differentiation (GO:0002335) | 3.54748636 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.54259391 |
| 46 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.53752563 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52006999 |
| 48 | activated T cell proliferation (GO:0050798) | 3.51695072 |
| 49 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.48572785 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.47555491 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.45843848 |
| 52 | positive regulation of isotype switching (GO:0045830) | 3.43968789 |
| 53 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.40806765 |
| 54 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.40609780 |
| 55 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.40609780 |
| 56 | * positive regulation of interleukin-2 production (GO:0032743) | 3.39196281 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.38314737 |
| 58 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.38314737 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 3.36329402 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.32701135 |
| 61 | B cell proliferation (GO:0042100) | 3.31934047 |
| 62 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.31865526 |
| 63 | positive regulation of tolerance induction (GO:0002645) | 3.27539810 |
| 64 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27219304 |
| 65 | leukocyte cell-cell adhesion (GO:0007159) | 3.26855166 |
| 66 | T cell homeostasis (GO:0043029) | 3.26209545 |
| 67 | lymphocyte homeostasis (GO:0002260) | 3.24232080 |
| 68 | Peyers patch development (GO:0048541) | 3.23279079 |
| 69 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.23279079 |
| 70 | germinal center formation (GO:0002467) | 3.22954069 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20870072 |
| 72 | mast cell activation (GO:0045576) | 3.20322026 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19698827 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.19662290 |
| 75 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18665336 |
| 76 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16234358 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.10206143 |
| 78 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09145329 |
| 79 | B cell homeostasis (GO:0001782) | 3.08417872 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.08063569 |
| 81 | natural killer cell differentiation (GO:0001779) | 3.07497091 |
| 82 | regulation of response to interferon-gamma (GO:0060330) | 3.06756953 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05958405 |
| 84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05895899 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 3.05895899 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05895899 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05895899 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05895899 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 3.05895899 |
| 90 | positive regulation of immunoglobulin production (GO:0002639) | 3.05655125 |
| 91 | negative regulation of phagocytosis (GO:0050765) | 3.04988575 |
| 92 | positive regulation of histone deacetylation (GO:0031065) | 3.04386121 |
| 93 | cellular extravasation (GO:0045123) | 3.03994254 |
| 94 | response to protozoan (GO:0001562) | 3.03656886 |
| 95 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.02849925 |
| 96 | * regulation of B cell proliferation (GO:0030888) | 3.00482930 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.98978498 |
| 98 | natural killer cell activation (GO:0030101) | 2.98925668 |
| 99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.98207531 |
| 100 | histone H3-K36 demethylation (GO:0070544) | 2.97904030 |
| 101 | T cell proliferation (GO:0042098) | 2.96894734 |
| 102 | regulation of alpha-beta T cell activation (GO:0046634) | 2.96329005 |
| 103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95357088 |
| 104 | positive regulation of DNA recombination (GO:0045911) | 2.92594541 |
| 105 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92056184 |
| 106 | B cell mediated immunity (GO:0019724) | 2.91708280 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91538722 |
| 108 | negative regulation of type 2 immune response (GO:0002829) | 2.90985806 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.90812940 |
| 110 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90520595 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.90245124 |
| 112 | lymphocyte migration (GO:0072676) | 2.90215188 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89685163 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 2.89517966 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89289903 |
| 116 | signal complex assembly (GO:0007172) | 2.88007772 |
| 117 | regulation of isotype switching (GO:0045191) | 2.87645488 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.87640688 |
| 119 | positive regulation of humoral immune response (GO:0002922) | 2.87265362 |
| 120 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.86397416 |
| 121 | positive regulation of B cell mediated immunity (GO:0002714) | 2.86397416 |
| 122 | response to type I interferon (GO:0034340) | 2.85548836 |
| 123 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83462295 |
| 124 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.82234582 |
| 125 | regulation of B cell mediated immunity (GO:0002712) | 2.82196778 |
| 126 | * positive regulation of B cell activation (GO:0050871) | 2.81842366 |
| 127 | mast cell degranulation (GO:0043303) | 2.81386674 |
| 128 | mast cell activation involved in immune response (GO:0002279) | 2.81386674 |
| 129 | mononuclear cell proliferation (GO:0032943) | 2.80101295 |
| 130 | myeloid dendritic cell differentiation (GO:0043011) | 2.80048530 |
| 131 | negative regulation of B cell proliferation (GO:0030889) | 2.77350040 |
| 132 | type I interferon signaling pathway (GO:0060337) | 2.77273003 |
| 133 | cellular response to type I interferon (GO:0071357) | 2.77273003 |
| 134 | defense response to protozoan (GO:0042832) | 2.76573549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.97741041 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.34923889 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.09289676 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.09159784 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.86630698 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49432654 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30880151 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.29915606 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.29356892 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.21895900 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.20025781 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.17425161 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13279757 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.93799011 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.92752560 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.83395406 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77220869 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76169953 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.71304446 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69584339 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.62739431 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53957910 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.52569758 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.44443576 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35826965 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25719623 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19396593 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17383492 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15721675 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.12260747 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.11962506 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08700956 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06495845 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02523352 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.96954584 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96121999 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94348522 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91808487 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91678885 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85950039 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82613713 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82293365 |
| 43 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76719201 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76617345 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76590257 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69571053 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60475716 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.51707979 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50350312 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48880943 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48143354 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43402080 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38154226 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35558010 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33839153 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27541166 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26585831 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22825838 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21991177 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21106961 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20597902 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20018807 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19508678 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14992488 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13137300 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12831393 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12373331 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08550785 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07137835 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06544250 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05026571 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04828159 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03835821 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03009223 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00552403 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99089093 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98954791 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94029239 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93593475 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92960752 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91706891 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90565999 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90448958 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90366804 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89969503 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89575881 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87535648 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85931136 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85410961 |
| 90 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.83276509 |
| 91 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82469275 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81360127 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80850504 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80695603 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.79769947 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78702006 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78319088 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78123591 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77729548 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77592744 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76562843 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.73612390 |
| 103 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.73570000 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72875944 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72808897 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72320232 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72252695 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72173182 |
| 109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.71018219 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69794086 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.69661254 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.69269143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.48229245 |
| 2 | * MP0001800_abnormal_humoral_immune | 3.94415811 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.88049690 |
| 4 | * MP0001790_abnormal_immune_system | 3.87884735 |
| 5 | * MP0005387_immune_system_phenotype | 3.87884735 |
| 6 | MP0000685_abnormal_immune_system | 3.59139605 |
| 7 | MP0005671_abnormal_response_to | 3.55957564 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.24018771 |
| 9 | * MP0002452_abnormal_antigen_presenting | 3.22432114 |
| 10 | * MP0002723_abnormal_immune_serum | 3.05607541 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 3.01667213 |
| 12 | MP0003303_peritoneal_inflammation | 2.97423585 |
| 13 | * MP0001819_abnormal_immune_cell | 2.96082441 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.76882459 |
| 15 | MP0004510_myositis | 2.73215907 |
| 16 | MP0001873_stomach_inflammation | 2.57993105 |
| 17 | MP0003436_decreased_susceptibility_to | 2.54888950 |
| 18 | * MP0000716_abnormal_immune_system | 2.53202323 |
| 19 | MP0005025_abnormal_response_to | 2.46441539 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.42917400 |
| 21 | * MP0000689_abnormal_spleen_morphology | 2.33523439 |
| 22 | MP0002419_abnormal_innate_immunity | 2.30896126 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.25520700 |
| 24 | * MP0002405_respiratory_system_inflammati | 2.24692398 |
| 25 | MP0009785_altered_susceptibility_to | 2.23824060 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.22104898 |
| 27 | * MP0002722_abnormal_immune_system | 2.18975927 |
| 28 | * MP0002429_abnormal_blood_cell | 2.05414559 |
| 29 | MP0000703_abnormal_thymus_morphology | 2.04463032 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.04099354 |
| 31 | MP0002396_abnormal_hematopoietic_system | 2.03419780 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.00171536 |
| 33 | MP0003866_abnormal_defecation | 1.89327364 |
| 34 | MP0006082_CNS_inflammation | 1.81511775 |
| 35 | MP0002006_tumorigenesis | 1.79905136 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.79324381 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.75326383 |
| 38 | MP0001853_heart_inflammation | 1.70911855 |
| 39 | * MP0004947_skin_inflammation | 1.67056441 |
| 40 | MP0002933_joint_inflammation | 1.58977844 |
| 41 | MP0005451_abnormal_body_composition | 1.57437999 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.56947300 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.55356857 |
| 44 | MP0005310_abnormal_salivary_gland | 1.51455165 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.43089285 |
| 46 | MP0008260_abnormal_autophagy | 1.36938195 |
| 47 | MP0003724_increased_susceptibility_to | 1.32244625 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.27885979 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.25407718 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.22356108 |
| 51 | MP0009278_abnormal_bone_marrow | 1.21973403 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.18297100 |
| 53 | MP0003448_altered_tumor_morphology | 1.15451550 |
| 54 | * MP0008469_abnormal_protein_level | 1.13184349 |
| 55 | MP0000858_altered_metastatic_potential | 1.11397817 |
| 56 | MP0000490_abnormal_crypts_of | 1.07997246 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.05620487 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.05389945 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.03019818 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.01776754 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.01776754 |
| 62 | MP0003172_abnormal_lysosome_physiology | 0.96267872 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.96129135 |
| 64 | MP0001851_eye_inflammation | 0.90396346 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.89632781 |
| 66 | MP0008057_abnormal_DNA_replication | 0.86246140 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.77547042 |
| 68 | MP0005058_abnormal_lysosome_morphology | 0.77190924 |
| 69 | MP0003045_fibrosis | 0.76987933 |
| 70 | MP0004883_abnormal_blood_vessel | 0.75220763 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.74245370 |
| 72 | MP0002136_abnormal_kidney_physiology | 0.73563978 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.72794615 |
| 74 | MP0002009_preneoplasia | 0.72172172 |
| 75 | MP0003091_abnormal_cell_migration | 0.71354248 |
| 76 | MP0001663_abnormal_digestive_system | 0.71183104 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.71135142 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.70382181 |
| 79 | MP0009840_abnormal_foam_cell | 0.69567736 |
| 80 | MP0003077_abnormal_cell_cycle | 0.69313437 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.68589595 |
| 82 | MP0009764_decreased_sensitivity_to | 0.68506242 |
| 83 | MP0010307_abnormal_tumor_latency | 0.68067344 |
| 84 | MP0002132_abnormal_respiratory_system | 0.67300654 |
| 85 | MP0002254_reproductive_system_inflammat | 0.64616856 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.64532082 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.61281422 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.59388960 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.59114977 |
| 90 | MP0005023_abnormal_wound_healing | 0.58615843 |
| 91 | MP0002163_abnormal_gland_morphology | 0.58337141 |
| 92 | MP0009763_increased_sensitivity_to | 0.58017551 |
| 93 | MP0000609_abnormal_liver_physiology | 0.56183100 |
| 94 | MP0005166_decreased_susceptibility_to | 0.54279691 |
| 95 | MP0000249_abnormal_blood_vessel | 0.52611553 |
| 96 | MP0003795_abnormal_bone_structure | 0.52291077 |
| 97 | MP0003828_pulmonary_edema | 0.52193519 |
| 98 | MP0002928_abnormal_bile_duct | 0.51873603 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.51520612 |
| 100 | MP0000371_diluted_coat_color | 0.49412813 |
| 101 | MP0004381_abnormal_hair_follicle | 0.48994866 |
| 102 | MP0005621_abnormal_cell_physiology | 0.48509218 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.48123331 |
| 104 | MP0010094_abnormal_chromosome_stability | 0.47692179 |
| 105 | MP0008874_decreased_physiological_sensi | 0.47607056 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.47222750 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.45724831 |
| 108 | MP0000313_abnormal_cell_death | 0.45575014 |
| 109 | MP0003690_abnormal_glial_cell | 0.44503904 |
| 110 | MP0004130_abnormal_muscle_cell | 0.42752013 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.42424746 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.42417187 |
| 113 | MP0000604_amyloidosis | 0.41959559 |
| 114 | MP0005390_skeleton_phenotype | 0.41881076 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.41683233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 5.56174605 |
| 2 | Agammaglobulinemia (HP:0004432) | 5.50656664 |
| 3 | Recurrent viral infections (HP:0004429) | 4.98273928 |
| 4 | T lymphocytopenia (HP:0005403) | 4.97254157 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 4.78475705 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.74366354 |
| 7 | Chronic otitis media (HP:0000389) | 4.73031055 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.63176076 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.58268861 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 4.28537686 |
| 11 | Inflammation of the large intestine (HP:0002037) | 4.28504875 |
| 12 | Colitis (HP:0002583) | 4.26890356 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.24303392 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.20623949 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.19593521 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.19593521 |
| 17 | Recurrent sinusitis (HP:0011108) | 4.18025388 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 4.14468284 |
| 19 | Cellulitis (HP:0100658) | 4.04170609 |
| 20 | Abnormality of T cells (HP:0002843) | 3.99612485 |
| 21 | Meningitis (HP:0001287) | 3.92656461 |
| 22 | Lymphopenia (HP:0001888) | 3.85140474 |
| 23 | Nasal polyposis (HP:0100582) | 3.83999314 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.74161711 |
| 25 | Verrucae (HP:0200043) | 3.67966664 |
| 26 | Papilloma (HP:0012740) | 3.67966664 |
| 27 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.67384422 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.66278385 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.63680119 |
| 30 | Vasculitis (HP:0002633) | 3.58016704 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56839025 |
| 32 | Pustule (HP:0200039) | 3.52150534 |
| 33 | * IgM deficiency (HP:0002850) | 3.46522085 |
| 34 | Stomatitis (HP:0010280) | 3.35009925 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.34403534 |
| 36 | Recurrent skin infections (HP:0001581) | 3.33584084 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 3.26646865 |
| 38 | IgA deficiency (HP:0002720) | 3.25503432 |
| 39 | Emphysema (HP:0002097) | 3.22214802 |
| 40 | Chronic sinusitis (HP:0011109) | 3.21832812 |
| 41 | Thyroiditis (HP:0100646) | 3.21608839 |
| 42 | Abnormality of the nasal mucosa (HP:0000433) | 3.19992034 |
| 43 | Combined immunodeficiency (HP:0005387) | 3.17055801 |
| 44 | IgG deficiency (HP:0004315) | 3.15107137 |
| 45 | Myositis (HP:0100614) | 3.13766123 |
| 46 | Bronchitis (HP:0012387) | 3.08244592 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.05302075 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 3.03532527 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 3.00522764 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.97522182 |
| 51 | B lymphocytopenia (HP:0010976) | 2.97522182 |
| 52 | Chronic diarrhea (HP:0002028) | 2.97120114 |
| 53 | Increased IgM level (HP:0003496) | 2.94881192 |
| 54 | Obstructive lung disease (HP:0006536) | 2.86261476 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86261476 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.79423503 |
| 57 | Increased IgE level (HP:0003212) | 2.78989486 |
| 58 | Restrictive lung disease (HP:0002091) | 2.74279330 |
| 59 | Encephalitis (HP:0002383) | 2.69609753 |
| 60 | Recurrent otitis media (HP:0000403) | 2.69442299 |
| 61 | Eosinophilia (HP:0001880) | 2.66859244 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.66260517 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.65095932 |
| 64 | Osteomyelitis (HP:0002754) | 2.61607175 |
| 65 | Urticaria (HP:0001025) | 2.60862583 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.55229657 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54778286 |
| 68 | Lymphoma (HP:0002665) | 2.54320709 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.53441592 |
| 70 | Leukocytosis (HP:0001974) | 2.49346830 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.39366627 |
| 72 | Optic neuritis (HP:0100653) | 2.39366627 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.39234178 |
| 74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37625125 |
| 75 | Increased density of long bones (HP:0006392) | 2.35363146 |
| 76 | Hypochromic anemia (HP:0001931) | 2.33091125 |
| 77 | Granulocytopenia (HP:0001913) | 2.30900910 |
| 78 | Thrombocytosis (HP:0001894) | 2.30589828 |
| 79 | Sepsis (HP:0100806) | 2.27499443 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.26140657 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.25451475 |
| 82 | Gingivitis (HP:0000230) | 2.25292930 |
| 83 | Periodontitis (HP:0000704) | 2.24549684 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.21565811 |
| 85 | Papilledema (HP:0001085) | 2.21436259 |
| 86 | Pulmonary embolism (HP:0002204) | 2.18912186 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 2.17874676 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.17322604 |
| 89 | Skin ulcer (HP:0200042) | 2.17218985 |
| 90 | Orchitis (HP:0100796) | 2.16970783 |
| 91 | Hemoptysis (HP:0002105) | 2.15156911 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.14903987 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.14495006 |
| 94 | Arterial thrombosis (HP:0004420) | 2.10318441 |
| 95 | Viral hepatitis (HP:0006562) | 2.09926122 |
| 96 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.08251343 |
| 97 | Acute hepatic failure (HP:0006554) | 2.07226011 |
| 98 | Leukopenia (HP:0001882) | 2.05418247 |
| 99 | Basal cell carcinoma (HP:0002671) | 2.05283301 |
| 100 | Skin rash (HP:0000988) | 2.01009188 |
| 101 | Epistaxis (HP:0000421) | 2.00235429 |
| 102 | Cheilitis (HP:0100825) | 2.00126508 |
| 103 | Chest pain (HP:0100749) | 1.99483601 |
| 104 | Abnormality of the pleura (HP:0002103) | 1.98694654 |
| 105 | Abnormality of the prostate (HP:0008775) | 1.98434317 |
| 106 | Vertebral arch anomaly (HP:0008438) | 1.96525649 |
| 107 | Gingival bleeding (HP:0000225) | 1.93136686 |
| 108 | Anorexia (HP:0002039) | 1.92914414 |
| 109 | Petechiae (HP:0000967) | 1.92889378 |
| 110 | Fatigue (HP:0012378) | 1.91637838 |
| 111 | Myocardial infarction (HP:0001658) | 1.90958676 |
| 112 | Joint swelling (HP:0001386) | 1.88138493 |
| 113 | Arthralgia (HP:0002829) | 1.87005233 |
| 114 | Hematochezia (HP:0002573) | 1.83637350 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.79054916 |
| 116 | Hepatitis (HP:0012115) | 1.76366312 |
| 117 | Acrocyanosis (HP:0001063) | 1.75228338 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.73796142 |
| 119 | Persistence of primary teeth (HP:0006335) | 1.73213499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MAP4K1 | 5.61073175 |
| 2 | PRPF4B | 3.71991691 |
| 3 | TXK | 3.24264702 |
| 4 | STK10 | 2.99015469 |
| 5 | GRK6 | 2.74616986 |
| 6 | TYK2 | 2.65502461 |
| 7 | JAK3 | 2.64547996 |
| 8 | BLK | 2.58415179 |
| 9 | ITK | 2.46487201 |
| 10 | MAP3K14 | 2.29980157 |
| 11 | ZAP70 | 2.29909001 |
| 12 | MAP3K10 | 2.23982680 |
| 13 | JAK1 | 2.22634861 |
| 14 | SYK | 2.10239433 |
| 15 | MAP3K13 | 1.97575216 |
| 16 | BTK | 1.92675625 |
| 17 | FGFR4 | 1.91162666 |
| 18 | CSF1R | 1.90498831 |
| 19 | SMG1 | 1.89741911 |
| 20 | EEF2K | 1.89174040 |
| 21 | CDK12 | 1.80606833 |
| 22 | CSK | 1.79214827 |
| 23 | LRRK2 | 1.77242591 |
| 24 | IKBKE | 1.72830050 |
| 25 | ERN1 | 1.70408251 |
| 26 | TBK1 | 1.67615034 |
| 27 | SIK2 | 1.65406891 |
| 28 | HCK | 1.63575443 |
| 29 | KIT | 1.59580368 |
| 30 | LCK | 1.57582926 |
| 31 | FGFR3 | 1.54319615 |
| 32 | PASK | 1.50428813 |
| 33 | MARK3 | 1.48195587 |
| 34 | MST4 | 1.42085617 |
| 35 | TEC | 1.40933550 |
| 36 | IRAK4 | 1.40631894 |
| 37 | IKBKB | 1.39802526 |
| 38 | IRAK3 | 1.38295120 |
| 39 | RIPK4 | 1.37075945 |
| 40 | CLK1 | 1.33022326 |
| 41 | TGFBR2 | 1.28258433 |
| 42 | FES | 1.26719477 |
| 43 | PIM1 | 1.23763135 |
| 44 | TRIB3 | 1.23358915 |
| 45 | NLK | 1.20115619 |
| 46 | PRKCH | 1.18631457 |
| 47 | PKN2 | 1.15198473 |
| 48 | LYN | 1.13936717 |
| 49 | BMPR2 | 1.05386364 |
| 50 | EPHB1 | 1.04588860 |
| 51 | RPS6KA4 | 0.97062750 |
| 52 | CHUK | 0.95826513 |
| 53 | CDC42BPA | 0.94668833 |
| 54 | SIK3 | 0.92375173 |
| 55 | JAK2 | 0.90297165 |
| 56 | TNK2 | 0.89455009 |
| 57 | * PRKCQ | 0.88292066 |
| 58 | MAP3K1 | 0.86919650 |
| 59 | TAOK3 | 0.86209110 |
| 60 | BRD4 | 0.78100491 |
| 61 | MAP3K11 | 0.77064564 |
| 62 | ALK | 0.77036210 |
| 63 | MAP3K3 | 0.72882160 |
| 64 | TTN | 0.71372992 |
| 65 | HIPK2 | 0.67210430 |
| 66 | TAOK2 | 0.66575380 |
| 67 | FGR | 0.65610933 |
| 68 | MAP3K7 | 0.65402953 |
| 69 | CDK4 | 0.65222316 |
| 70 | EPHA3 | 0.64781376 |
| 71 | MAP2K3 | 0.63517012 |
| 72 | PDK1 | 0.62166237 |
| 73 | PRKD2 | 0.60943247 |
| 74 | CAMKK1 | 0.60873652 |
| 75 | KSR2 | 0.60210133 |
| 76 | MELK | 0.56658276 |
| 77 | YES1 | 0.54224084 |
| 78 | SIK1 | 0.53292117 |
| 79 | NME2 | 0.52778518 |
| 80 | CDK9 | 0.52702317 |
| 81 | PTK6 | 0.52698779 |
| 82 | TESK2 | 0.52009152 |
| 83 | MAPK7 | 0.51288887 |
| 84 | IRAK1 | 0.50912984 |
| 85 | PDPK1 | 0.47898421 |
| 86 | ABL1 | 0.46424861 |
| 87 | IRAK2 | 0.44955992 |
| 88 | CDK6 | 0.44912063 |
| 89 | NEK2 | 0.44515743 |
| 90 | CAMK1G | 0.44365599 |
| 91 | INSR | 0.42953003 |
| 92 | RIPK1 | 0.42439499 |
| 93 | ICK | 0.42347707 |
| 94 | STK24 | 0.42010688 |
| 95 | CAMK1D | 0.41319667 |
| 96 | FYN | 0.40118888 |
| 97 | KDR | 0.40089058 |
| 98 | MAP3K8 | 0.40027762 |
| 99 | RPS6KA6 | 0.39911721 |
| 100 | TAOK1 | 0.39809266 |
| 101 | MAPK4 | 0.37178816 |
| 102 | DMPK | 0.36978680 |
| 103 | MAPK12 | 0.36903543 |
| 104 | PDGFRB | 0.36467245 |
| 105 | STK4 | 0.36255249 |
| 106 | MAP2K2 | 0.36252687 |
| 107 | TYRO3 | 0.34690199 |
| 108 | MARK2 | 0.33580669 |
| 109 | EGFR | 0.32342854 |
| 110 | MAPKAPK2 | 0.31328306 |
| 111 | RPS6KL1 | 0.29529622 |
| 112 | RPS6KC1 | 0.29529622 |
| 113 | SGK3 | 0.29291188 |
| 114 | MATK | 0.28608236 |
| 115 | BMX | 0.27218802 |
| 116 | MAPK3 | 0.26983179 |
| 117 | RET | 0.26143299 |
| 118 | MAPK11 | 0.26097464 |
| 119 | TRPM7 | 0.25739509 |
| 120 | NEK9 | 0.25150676 |
| 121 | PRKCD | 0.21415953 |
| 122 | PRKD1 | 0.19776448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.24193434 |
| 2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.61582185 |
| 3 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.79052912 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66644546 |
| 5 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.60451868 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.55877322 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52456264 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.46208297 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45258603 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43512911 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31214051 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.31182935 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98888511 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71424850 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70880289 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58450950 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57873086 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55080442 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54584533 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54277760 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52050593 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51429383 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49184466 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48914272 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.48750792 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46910052 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.43887969 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.37160036 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.34401984 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.33572932 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.30727265 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25300098 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23249476 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17352536 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15773105 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.14625917 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11483123 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10932618 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.05333223 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00712560 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98253545 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.98039193 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96016191 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95908603 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95462692 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95245332 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94050705 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92605573 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91500939 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90388960 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.84418628 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84020822 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.83733096 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.83419174 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80705340 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79625245 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79042289 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78660423 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74331313 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.71878888 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.68787879 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67227754 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66447957 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66406243 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63570451 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63261464 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60547502 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59210270 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.58705016 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58691770 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57623199 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57037367 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55779866 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.54643489 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.51306035 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.50480140 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.49846294 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49557868 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49510678 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48939505 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48680151 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48668542 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48501008 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47518861 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46434921 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45528883 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.45259320 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.44663382 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43818841 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42919685 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41570014 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40738681 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40642005 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.38986840 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38920668 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38637360 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38050164 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.37018134 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36345501 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36117403 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35221989 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34729114 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34313927 |
| 104 | DNA replication_Homo sapiens_hsa03030 | 0.34238437 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32956210 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31459506 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30849875 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30539886 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30493714 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29779384 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28740250 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28534759 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27116223 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26404849 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25685889 |

